Description: Tilray Inc is a Canada-based company engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.
Home Page: www.tilray.com
TLRY Technical Analysis
265 Talbot Street West
Leamington,
ON
N8H 5L4
Canada
Phone:
844 845 7291
Officers
| Name | Title |
|---|---|
| Mr. Irwin David Simon | Pres, CEO & Chairman |
| Mr. Carl A. Merton CA, CBV, CPA | CFO & Principal Accounting Officer |
| Mr. Mitchell S. Gendel | Global Gen. Counsel & Corp. Sec. |
| Mr. James R. Meiers | Sr. VP of U.S. Operations |
| Ms. Denise Menikheim Faltischek | Chief Strategy Officer & Head of International |
| Mr. Lloyd Brathwaite | Chief Information Officer |
| Mr. Roger Savell | Chief Admin. Officer |
| Mr. John B. Sadler | VP of Investor Relations |
| Ms. Dara S. Redler | Interim Chief Legal Officer & Corp. Sec. |
| Mr. Bernard Yeung | Sr. VP of Sales & Marketing |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 1000 |
|---|---|
| Trailing PE: | 6.8049 |
| Price-to-Book MRQ: | 0.458 |
| Price-to-Sales TTM: | 3.2087 |
| IPO Date: | 2018-07-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 1700 |